News
NAGE
6.45
-3.73%
-0.25
Weekly Report: what happened at NAGE last week (1124-1128)?
Weekly Report · 4d ago
Niagen Bioscience management to meet with Roth Capital
TipRanks · 11/25 18:35
Weekly Report: what happened at NAGE last week (1117-1121)?
Weekly Report · 11/24 09:22
CFO’s Bold Move: Major Stock Purchase in Niagen Bioscience!
TipRanks · 11/18 02:12
Niagen Bioscience CFO Pamir Ozan Acquires Common Shares
Reuters · 11/17 13:23
Roth MKM Reaffirms Their Buy Rating on Niagen Bioscience (NAGE)
TipRanks · 11/17 12:55
Canaccord Genuity Reaffirms Their Buy Rating on Niagen Bioscience (NAGE)
TipRanks · 11/17 12:18
Weekly Report: what happened at NAGE last week (1110-1114)?
Weekly Report · 11/17 09:22
Niagen Bioscience: A Breakout Quarter That Now Faces Its Biggest Market Shift In Years
Seeking Alpha · 11/15 10:41
Niagen Bioscience Launches Tru Niagen Beauty Supplement In U.S.
Benzinga · 11/13 13:44
Niagen Biosciences Reports Results From First-ever Randomized Trial Of Niagen NR In Long COVID
NASDAQ · 11/13 12:03
Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside)
Barchart · 11/13 07:32
Niagen Bioscience announces results of Niagen supplementation in long COVID
TipRanks · 11/13 02:25
Niagen Bioscience Reports Clinical Trial Shows Niagen Supplement Boosts NAD+ and Eases Long COVID Symptoms
Reuters · 11/13 00:52
Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID
Barchart · 11/12 18:52
Weekly Report: what happened at NAGE last week (1103-1107)?
Weekly Report · 11/10 09:21
Niagen Bioscience launches $10M share repurchase program
Seeking Alpha · 11/06 14:12
*Niagen Bioscience Announces $10 Million Share Repurchase Program >NAGE
Dow Jones · 11/06 13:07
Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Niagen Bioscience (NAGE)
TipRanks · 11/06 11:40
ChromaDex Reports Record Growth Amid Strategic Expansions
TipRanks · 11/06 00:21
More
Webull provides a variety of real-time NAGE stock news. You can receive the latest news about Niagen Bioscience, Inc through multiple platforms. This information may help you make smarter investment decisions.
About NAGE
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.